【摘 要】
：
Background and Aims: Protein phosphatase 2A (PP2A) is associated with many cancers. This study aimed to clarify whether PPP2CA, which encodes the alpha isoform of the catalytic subunit of PP2A, plays a role in hepatocellular carcinoma (HCC) and to identif
【机 构】
：
Department of Hepatobiliary Surgery,Guangxi Medical University Cancer Hospital,Nanning,Guangxi,China
论文部分内容阅读
Background and Aims: Protein phosphatase 2A (PP2A) is associated with many cancers. This study aimed to clarify whether PPP2CA, which encodes the alpha isoform of the catalytic subunit of PP2A, plays a role in hepatocellular carcinoma (HCC) and to identify the potential underlying molecular pathways. Methods: Based on bioinformatics, public databases and our in-house RNA-Seq database, we analyzed the clinical value and molecular mechanism of PPP2CA in HCC. Results: Data were analyzed from 2,545 patients with HCC and 1,993 controls without HCC indexed in The Cancer Genome Atlas database, the Gene Expres-sion Omnibus database and our in-house RNA-Seq data-base. PPP2CA expression was significantly higher in HCC tissue than in non-cancerous tissues (standardized mean difference: 0.69, 95％ confidence interval [CI]: 0.50-0.89). PPP2CA expression was able to differentiate HCC from non-HCC, with an area under the summary receiv-er operator characteristic curve of 0.79 (95％ CI: 0.75-0.83). Immunohistochemistry of tissue sections confirmed that PPP2CA protein was up-regulated in HCC tissues. High PPP2CA expression in HCC patients was associated with shorter overall, progression-free and disease-free survival. Potential molecular pathways through which PP-P2CA may be involved in HCC were determined using miR-Walk 2.0 as well as analysis of Gene Ontology categories, Kyoto Encyclopedia of Genes and Genomes pathways, and protein-protein interaction networks. Conclusions: PP-P2CA is up-regulated in HCC and higher expression cor-relates with worse prognosis. PPP2CA shows potential as a diagnostic marker for HCC. Future studies should ex-amine whether PPP2CA contributes to HCC through the candidate microRNAs, pathways and hub genes identified in this study.
其他文献
Background and Aims: Chronic hepatitis B is the main cause of liver cancer. However, the most neglected group has been treatment-naive chronic hepatitis B patients with normal alanine aminotransferase (ALT). People have tended to subjectively assume that
Background and Aims: In the last decade, several sec-ond-line therapies followed by sorafenib in patients with ad-vanced hepatocellular carcinoma (HCC) have been reported. But the outcomes were different from each other. This me-ta-analysis aimed to evalu
Background and Aims: The survival rate of patients with hepatocellular carcinoma is variable. The abnormal expres-sion of RNA-binding proteins (RBPs) is closely related to the occurrence and development of malignant tumors. The pri-mary aim of this study
Background and Aims: The impact of coronavirus dis-ease-2019 (COVID-19) on liver function remains to be fully elucidated. This study was designed to investigate such and determine the clinical significance in determining mortality risk. Methods: A retrosp
Background and Aims: Acute-on-chronic liver failure (ACLF) is acute decompensation of liver function in the setting of chronic liver disease, and characterized by high short-term mortality. In this study, we sought to investi-gate the clinical course of p
Background and Aims: Screening for hepatopulmonary syndrome in cirrhotic patients is limited due to the need to perform contrast enhanced echocardiography (CEE) and arterial blood gas (ABG) analysis. We aimed to develop a simple and quick method to screen
Background and Aims: It is critical but challenging to predict the prognosis of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). This study systematically summarized and evaluated the quality and performance of available clinical predi
Background and Aims: The expression of discoidin do-main receptor 1 (DDR1) is commonly up-regulated and undergoes collagen-induced ectodomain (N-terminal) shed-ding during the progression of liver fibrosis. This study aimed to evaluate the clinical utilit
Background and Aims: Currently, insufficient clinical data are available to address whether low-level viremia (LLV) ob-served during antiviral treatment will adversely affect the clinical outcome or whether treatment strategies should be altered if LLV oc
Background and Aims: The overall survival (OS) of hepa-tocellular carcinoma (HCC) remains dismal. Bioinformatic analysis of transcriptome data could identify patients with poor OS and may facilitate clinical decision. This study aimed to develop a prognos